Cirrhosis Clinical Trial
Official title:
The Role of Real Time Elastography in the Noninvasive Assessment of Liver Fibrosis in Chronic Viral Hepatitis
AIM To evaluate the role of real time elastography (ARFI and Hitachi elastography) in noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis
INTRODUCTION
Establishing liver fibrosis grade in patients with chronic viral hepatitis is very important
for the prognostic assessment and in making the decision to initiate antiviral treatment.
Although the liver biopsy remains the gold standard, recent studies focused on establishing
the role of noninvasive methods in liver fibrosis grading.
Elastography is an imaging method which estimates tissue elasticity. The first elastography
method which appeared was Transient Elastography (TE), followed by Real Time Elastography
(RT-E) and Acoustic Radiation Force Impulse (ARFI). TE was a method especially developed for
noninvasive assessment of liver fibrosis as an alternative to liver biopsy. Unlike these,
RT-E and ARFI have multiple applications in diffuse and tumoral pathology.
Transient Elastography (FibroScan) represents a noninvasive method useful in detecting the
degree of liver fibrosis. The ultrasound transducer probe is able to generate elastic shear
waves that propagate through the liver tissue as well as to measure their speed in the
tissue. Wave speed is directly related to tissue stiffness which is expressed in kilopascals
[1]. Initially, this method was validated for use and considered for chronic hepatitis
management guidelines, then for human immunodeficiency virus/hepatitis C virus (HCV)
co-infection and cholestatic liver diseases. FibroScan failures to give reliable results in
obese patients were reduced by developing a new XL probe which facilitated an alternative
noninvasive method to liver biopsy for liver fibrosis assessment [2].
Acoustic Radiation Force Impulse (ARFI) was proposed as an alternative to FibroScan for the
assessment of liver tissue elasticity, using a conventional ultrasound machine. The main
advantages of this method are the possibility of producing real-time images and its
feasibility in patients with ascites. Preliminary studies show better results for predicting
advanced grades of liver fibrosis than for mild to moderate fibrosis where the method is
less sensitive [3].
Real Time Elastography (RT-E) estimates relative tissue stiffness based on soft tissue
distortion and data are provided as real time color images [4, 5]. This is a real time
method that could also be used for patients with ascites. The method is not validated for
liver fibrosis assessment as there are few studies published so far. The appearance of the
elastography software on the convex probe with high penetration and possibility for
elastography to visualize the liver entirely and the development of information elastography
measurement information programs open new perspectives in noninvasive assessment of liver
pathology by RT-E. There are two recent studies showing good results of the software for
quantitative analysis in RT-E equipment.
The aim of this study is to establish the role of elastographic methods (ARFI and RT-E) in
liver fibrosis assessment in patients with chronic viral hepatitis. This multicentric
prospective trial will be approved by the ethical committee of each centre.
AIM To evaluate the role of real time elastography (ARFI and Hitachi elastography) in
noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis.
MATERIAL AND METHODS
- All patients are enrolled consecutively.
- Patient data are collected (name initials, age, sex, Civil Registration Number), liver
disease etiology, anthropometric data (body mass index).
- The following blood parameters are included: aspartate aminotransferase (AST), alanine
aminotransferase (ALT), γ -glutamyl transpeptidase, γ globulins, platelet count
- The following indices are calculated: AST/ALT; AST-to-platelet ratio index (APRI);
AST/upper limit of normal 100/platelet count (104 /mm3 ) , and FibroIndex [1.738 0.064
x platelet count (104 /mm3 ) + 0.005 x AST (U/l) + 0.463 x γ -globulin (g/dl)]
- Transient elastography is performed using FibroScan (FibroScan, Echosens) with the
patient lying in the dorsal decubitus position and with his right arm in maximum
abduction. The tip of the transducer probe is placed in the median axillary line in the
intercostal space corresponding to the right lobe of the liver. The pressure index on
the screen indicates that the pressure applied with the probe is compatible with the
measurement. Ten measurements per examination are necessary for good accuracy of the
stiffness assessment, considering the final result expressed in kilopascals as the mean
of the ten measurements. M and XL probes for obese patients are used.
- Hitachi Real Time Ultrasound Elastography is performed using the 5-1 MHz (EUP) convex
transducer from Hitachi Preirus equipment (Hitachi Aloka Medical Tokyo, Japan). Dual
imaging is set in such a manner as to be visible on the screen in a 2D image as well as
in an elastographic image juxtaposed over the 2D image. The examination is underwent
through two points: intercostally through the right lobe and epigastrically through
left hepatic lobe. The examination is done through post-expiratory apnea without
compression on the probe. The interest region (ROI) is set at 4cm², 1 cm under the
liver capsule. The aria of interest is chosen so that the 2D image is as clear as
possible, the large vessels avoided and the artifacts given by ribs and lungs. For each
patient, 10 images are chosen with two entry points (intercostally and epigastrically).
For each image the 11 parameters given by the Strain Histogram measurement software are
used: mean relative strain value (MEAN); standard deviation of relative strain value
(SD); percentage of low strain area (percentage of blue color area - %AREA); complexity
of low strain area (calculated as perimeter 2 /area - COMP); skewness (SKEW); kurtosis
(KURT); contrast (CONT); entropy (ENT); textural complexity, inverse difference moment
(IDM); angular second moment (ASM); Correlation (CORR) indicates the feature value of
the texture directivity.
- ARFI- Acoustic Radiation Force Impulse Technology [ACUSON S2000]. Scanning is performed
with a right intercostal approach, in the right liver lobe, segment V-VIII, 1-2 cm
under the liver capsule, with minimal scanning pressure applied by the operator, while
the patients is asks to stop normal breathing for a moment, in order to minimize
breathing motion. The operator selects the depth at which the liver elasticity is
evaluated by placing a "measuring box" (10 mm long, 5 mm wide) in the desired area. The
maximum depth at which ARFI measurements can be performed is 8 cm. A total of 10 valid
measurements performe in every patient and a median value in m/s is calculate.
- Liver biopsy samples is takes via a right intercostal space from the right liver lobe
with direct sonographic guidance. Liver fibrosis stages is evaluate semiquantitatively
according to the METAVIR scoring system on an F0-F4 scale
Statistical analysis
The diagnostic performance of ARFI and RT-E for liver fibrosis will determine in terms of
sensitivity, specificity, positive predictive value, negative predictive value, diagnostic
accuracy and area under the receiver operating characteristic curve (AUROC).
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01884415 -
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
|
Phase 3 | |
Recruiting |
NCT05014594 -
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
|
Phase 2 | |
Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
Completed |
NCT04939350 -
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
|
||
Completed |
NCT02528760 -
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
|
N/A | |
Recruiting |
NCT05484206 -
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
|
Phase 1 | |
Not yet recruiting |
NCT05538546 -
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
|
||
Not yet recruiting |
NCT04053231 -
Hepatocarcinoma Recurrence on the Liver Study - Part2
|
||
Recruiting |
NCT02983968 -
Use of the French Healthcare Insurance Database
|
||
Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
Completed |
NCT02596880 -
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
|
Phase 3 | |
Completed |
NCT02247414 -
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
|
Phase 4 | |
Completed |
NCT02016196 -
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
|
Phase 3 | |
Withdrawn |
NCT01956864 -
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
|
Phase 1 | |
Completed |
NCT01447537 -
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
|
N/A | |
Completed |
NCT02113631 -
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Active, not recruiting |
NCT01205074 -
¹³C-Methacetin Breath Test (MBT) Methodology Study
|
Phase 2/Phase 3 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01231828 -
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.
|
N/A |